Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30

$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Fabhalta Global Growth in Constant Currencies by Year

Name: Novartis Fabhalta Global Growth in Constant Currencies by Year (NVS)
Creator: Novartis

Fabhalta Global Growth in Constant Currencies (% cc) (%)

Quarterly Annual

Novartis Fabhalta Global Growth in Constant Currencies: 287.0% in FY2025.

Latest, FY2025

287.0%

Period ended Dec 31, 2025

Change on a year earlier

–

History

1 years

Since FY2025

Sources

Novartis Form 6-K (0001114448-26-000007)

Where the FY2025 figure comes from

“|| Fabhalta 3 | 505 | 129 | 291 | 287”

Source: Novartis Form 6-K (0001114448-26-000007) ↗

Reported in Form 6-K & Form 20-F.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Fabhalta Global Growth in Constant Currencies (% cc) (%)	Year on year	Source
FY2025	Dec 31, 2025	287.0%	–	Novartis Form 6-K (0001114448-26-000007) ↗

Cite this data

StockData. (2026). Novartis Fabhalta Global Growth in Constant Currencies (%), annual FY2025–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-fabhalta-yoy-cc-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.